Linc Energy Ltd ADR (LNCGY) 0.4500 $LNCGY Where

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Linc Energy Ltd ADR (LNCGY) 0.4500 $LNCGY

Where Investors Are Going -- Complementary Research on Sierra Resource Group, Propanc Health Group, US Highland and Linc Energy
ACCESSWIRE - Tue Jan 19, 8:00AM CST
NEW YORK, NY / ACCESSWIRE / January 19, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Sierra Resource Group Inc. (OTC: SIRG), Propanc Health Group Corp. (OTC: PPCH), US Highland Inc. (OTC: UHLN) and Linc Energy Ltd. (OTC: LNCGY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

KILL Linc Energy Signs Deal for US$100m Sale of Shale Oil (SAPEX) Asset
BusinessWire - Wed Nov 18, 10:25AM CST
CB3 and Linc Energy request that NewsItemId: 20151117007163, Linc Energy press release entitled "Linc Energy Signs Deal for US$100m Sale of Shale Oil (SAPEX) Asset" be killed.

Linc Energy Signs Deal for US$100m Sale of Shale Oil (SAPEX) Asset
BusinessWire - Tue Nov 17, 11:19PM CST
Singapore listed Australian energy company Linc Energy T16 has reportedly signed a deal to sell its Snake Oil asset in South Australia for a rumoured US$100m (Aus$140m).

Global Syngas & Derivatives Market 2015-2020 - End User, Feedstock, Production Technology & Gasifier Analysis
PR Newswire Europe - Tue Sep 15, 9:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q8p4ns/syngas_and [http://www.researchandmarkets.com/research/q8p4ns/syngas_and]) has announced the addition of the "Syngas & Derivatives Market by End Use (Chemicals, Power Generation, Liquid Fuels, Gaseous Fuels), by Feedstock (Coal, Petroleum, Natural Gas & Biomass/Waste), by Production Technology, & by Gasifier - Global Forecasts to 2020" [http://www.researchandmarkets.com/research/q8p4ns/syngas_and] report to their offering.
CBI: 36.26 (+0.51), GE: 30.60 (-0.04), SSL: 26.48 (-0.12), CF: 28.35 (+0.76), KBR: 13.62 (-0.16), AGU: 93.78 (+1.09), APD: 143.31 (-1.05), MEOH: 30.84 (+0.94)

Syngas & Derivatives Market 2015 - Global Forecasts to 2020: Feedstock Flexibility for the Syngas Production Drives the Increasing Demand
M2 - Tue Sep 15, 6:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t6qw6g/syngas_and) has announced the addition of the "Syngas & Derivatives Market by End Use (Chemicals, Power Generation, Liquid Fuels, Gaseous Fuels), by Feedstock (Coal, Petroleum, Natural Gas & Biomass/Waste), by Production Technology, & by Gasifier - Global Forecasts to 2020" report to their offering. The syngas and derivatives market is expected to grow at a CAGR of 9.5% between 2015 and 2020, to reach 213,100 MW thermal (MWth) by 2020. Asia- Pacific, with its thriving economies and rapidly expanding population, is expected to experience the highest consumption during the given period. The major driving factors of this market include the growing need for chemicals, fuels, and electricity, which can be generated simultaneously to meet the requirements of the increasing population. The other growth driver is the feedstock flexibility of syngas production process, which means that it can be produced either from coal, natural gas, petroleum- based products, or biomass/waste, depending on the availability. The consumption figures are further categorized on the basis of major countries in respective regions. Coal, natural gas, petroleum (petcoke and others), and biomass/waste are the four major feedstocks utilized for the production of syngas. Syngas production technologies identified and covered in the report are steam reforming, partial oxidation, autothermal reforming, combined or two- step reforming, and biomass gasification. The market has also been segmented in terms of types of gasifier utilized for the syngas production process. In addition, syngas consumption for several end uses, such as chemical, liquid fuel, power generation, and gaseous fuels, has been discussed in detail in this report. Consumption figures (MWth) for chemical derivatives, such as methanol, ammonia, oxo chemicals, n- butanol, hydrogen, and DME have been further described, by major regions and applications. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Syngas and Derivatives Market, By End Use 8 Syngas and Derivatives Market, By Feedstock 9 Syngas and Derivatives Market, By Production Technology 10 Syngas and Derivatives Market, By Gasifier Type 11 Syngas and Derivatives Market, By Region 12 Competitive Landscape 13 Company Profiles - AMEC Foster Wheeler PLC - Agrium Inc. - Air Liquide SA - Air Products and Chemicals, Inc. - BASF SE - Biomethanol Chemie Nederland B.V. - CF Industries Holdings Inc. - Chicago Bridge & Iron Company N.V. - General Electric Company - Haldor Topsoe A/S - KBR Inc. - KT-Kinetics Technology - Linc Energy Ltd. - Methanex Corporation - Mitsubishi Heavy Industries, Ltd. (MHI Group) - Oxea Gmbh (Oman Oil Company) - Royal Dutch Shell PLC - Sasol Limited - Siemens Ag - Syngas Technology LLC - Technip S.A. - The DOW Chemical Company - The Linde Group - Yara International ASA For more information visit http://www.researchandmarkets.com/research/t6qw6g/syngas_and
CBI: 36.26 (+0.51), GE: 30.60 (-0.04), SSL: 26.48 (-0.12), CF: 28.35 (+0.76), KBR: 13.62 (-0.16), AGU: 93.78 (+1.09), APD: 143.31 (-1.05), MEOH: 30.84 (+0.94)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading